Around, a distributed next-generation video collaboration service, raised $10M in Series A funding.
Turbine, a London, UK- and Budapest, Hungary-based company simulating cellular decision making to unlock novel oncology therapies, closed its €5.7m (USD 6.85m) pre-Series A funding round.
Flashpoint Venture Capital, a diversified international technology investment firm, is announcing the first close of its third venture capital fund targeting US$75-100m.
BitNinja, a Debrecen, Hungary-based website server protection solution provider, raised $2.5m in Series A funding.
AerinX, a Budapest, Hungary-based company that develops and provides digital aircraft maintenance solutions, raised €2M in Pre Series A funding.
VCC Live, a Budapest, Hungary-based cloud-based contact center software provider, secured $2.4M in funding.
Turbine, a Budapest, Hungary-based simulation-based drug discovery company, raised €3m in funding.
Shapr3D, a Budapest, Hungary-based startup that developed a 3D CAD modeling app for iPad Pro, raised US$6m in series A financing.
Bitrise, a Budapest, Hungary-based mobile continuous integration and delivery platform, raised $20m in series B funding.
Realeyes, a London, UK-based emotion AI company, raised $12.4M in funding.
Talentuno, a Budapest, Hungary-based HR tech startup, raised €4m in Series A funding.
Codecool, a Budapest, Hungary-based coding school, raised €3.5m in Series B funding.
Rollbar, a San Francisco, CA-based provider of Software as a Service real-time error monitoring software, acquired Samebug, a Budapest, Hungary-based platform for developers to find and share solutions to software problems.
Tresorit, a Zurich, Switzerland – Budapest, Hungary-based cloud encryption and collaboration company which provides end-to-end encrypted file sync & sharing for businesses, closed an €11.5M Series B financing.
Citoxlab Group, an Evreux, France-based non-clinical CRO player, is to acquire Solvo Biotechnology, a Budapest, Hungary-based CRO specializing in drug transporter studies and the assessment of Drug-Drug Interactions (DDI).